Table: Chugai Pharm -9-MTH group results (IFRS)

Chugai Pharmaceutical

22/10/2020 09:00

Oct 22 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2020        Sep 30, 2019     Dec 31, 2020 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              576.52              508.85                     
                   (+13.3 pct)         (+19.3 pct)                  
  Operating          227.32              160.88                     
                   (+41.3 pct)         (+64.3 pct)                  
  Pretax
  Net                162.43              117.40                     
                   (+38.4 pct)         (+66.9 pct)                  
  EPS Basic         98.84 yen           71.49 yen                   
  EPS Diluted       98.74 yen           71.39 yen                   
  Ann Div                              140.00 yen                   
  -Q2 Div           75.00 yen           48.00 yen                   
  -Q4 Div                               92.00 yen        25.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T